Precision Biosciences Inc (NASDAQ:DTIL) price on Thursday, July 03, rose 1.88% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.34.
A look at the stock’s price movement, the close in the last trading session was $4.26, moving within a range at $4.19 and $4.38. The beta value (5-Year monthly) was 1.468. Turning to its 52-week performance, $11.09 and $3.61 were the 52-week high and 52-week low respectively. Overall, DTIL moved -15.73% over the past month.
Precision Biosciences Inc’s market cap currently stands at around $48.13 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-15.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DTIL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend DTIL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
DTIL’s current price about -8.06% and -12.31% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.74, while 7-day volatility ratio is 5.39% and 7.32% in the 30-day chart. Further, Precision Biosciences Inc (DTIL) has a beta value of 1.51. Analysts have given the company’s stock an average 52-week price target of $15.5, forecast between a low of $1 and high of $30. Looking at the price targets, the low is 76.96% off current price level while to achieve the yearly target high, price needs to move -591.24%. Nonetheless, investors will most likely welcome a -257.14% jump to $15.5 which is the analysts’ median price.
If we refocus on Precision Biosciences Inc (NASDAQ:DTIL), historical trading data shows that trading volumes averaged 0.98 over the past 10 days and 268.57K over the past 3 months. The company’s latest data on shares outstanding shows there are 10.55 million shares.
The 27.15% of Precision Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 34.11% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.55 million on 2025-06-13, giving us a short ratio of 7.13. The data shows that as of 2025-06-13 short interest in Precision Biosciences Inc (DTIL) stood at 508.0 of shares outstanding, with shares short falling to 0.65 million registered in 2025-05-15. Current price change has pushed the stock -56.12% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DTIL stock continues to rise going into the next quarter.
